期刊文献+

从毒、瘀、虚探讨甲亢性心脏病的治疗

Exploring the Treatment of Hyperthyroidism Heart Disease from Toxicity,Stasis and Deficiency
下载PDF
导出
摘要 甲亢性心脏病是指继发于甲状腺功能亢进症的心脏疾病。中医将甲亢性心脏病归为“瘿病”合并“心悸”范畴,其病机为本虚标实、虚实错杂,以先天禀赋不足为本,火毒为该病之始,痰瘀为之形,气阴两虚为该病之终。在治疗上,以整体观为基础,立足“毒”“瘀”“虚”的病因病机,提出了“清热泻火解毒”“祛痰活血化瘀”“益气养阴温阳”的治则治法,以期提高临床治愈率,改善患者的生活质量。 Hyperthyroidism heart disease is a heart disease secondary to hyperthyroidism.In Chinese medicine,hyperthyroidism is classified as a“gall disease”combined with“palpitation”,and its pathology is a combination of deficiency and deficiency,with the deficiency of innate endowment as the basis,fire toxicity as the beginning of the disease,phlegm and blood stasis as the form,and deficiency of Qi and Yin as the end of the disease.In the treatment,based on the overall concept and the etiology of“toxicity”,“stasis”and“deficiency”,the treatment principle of“clearing heat and fire to remove toxins”,“dispelling phlegm and activating blood circulation to remove blood stasis”,and“benefiting Qi,nourishing Yin and warming Yang”were proposed in order to increase the clinical cure rate and improve the quality of life of the patients.
作者 张海洋 曾明星 向楠 左新河 郑雅琴 鲁志林 陈继东 Zhang Haiyang;Zeng Mingxing;Xiang Nan;Zuo Xinhe;Zheng Yaqin;Lu Zhilin;Chen Jidong(Hubei University of Chinese Medicine,Wuhan 430061,China;Chen Ruquan National Famous Traditional Chinese Medicine Inheritance Studio,Wuhan 430061,China;Wuhan Hankou Hospital,Wuhan 430012,China)
出处 《亚太传统医药》 2024年第8期220-224,共5页 Asia-Pacific Traditional Medicine
基金 陈如泉全国名老中医药专家传承工作室项目(国中医药人教函[2018]134号)。
关键词 甲亢性心脏病 中医药 瘿病 心悸 Hyperthyroid Heart Disease Chinese Medicine Gall Disease Palpitation
  • 相关文献

参考文献20

二级参考文献143

共引文献462

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部